Latest journal articles from HEDS

The following articles were published by researchers within HEDS in April.

Cabazitaxel for the Second-Line Treatmentof Metastatic Hormone-Refractory Prostate Cancer: A NICE Single TechnologyAppraisal.

Kearns B, Lloyd Jones M, Stevenson M, Littlewood C

Pharmacoeconomics 12 Apr 2013 Author URL DOI

Golimumab for the Treatment of RheumatoidArthritis After the Failure of Previous Disease-Modifying Antirheumatic Drugs:A NICE Single Technology Appraisal.

Tosh J, Archer R, Davis S, Stevenson M, Stevens JW

Pharmacoeconomics 11 Apr 2013 Author URL DOI

Heart-type fatty acid binding protein as anearly marker for myocardial infarction: Systematic review and meta-analysis

Carroll C, Khalaf MA, Stevens JW, Leaviss J, Goodacre S, Wang J, Collinson PO

Emergency Medicine Journal 30(4):280-286 Apr 2013 DOI

The clinical effectiveness andcost-effectiveness of cetuximab (mono- or combination chemotherapy),bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab(monotherapy) for the treatment of metastatic colorectal cancer afterfirst-line chemotherapy (review of technology appraisal No.150 and part reviewof technology appraisal No. 118): a systematic review and economic model.

Hoyle M, Crathorne L, Peters J, Jones-Hughes T, Cooper C, Napier M, Tappenden P, Hyde C

Health Technol Assess 17(14):1-237 Apr 2013 Author URL DOI

Bivalirudin for the Treatment of ST-SegmentElevation Myocardial Infarction: A NICE Single Technology Appraisal.

Simpson EL, Fitzgerald P, Evans P, Tappenden P, Kalita N, Reckless JP, Bakhai A

Pharmacoeconomics 31(4):269-275 Apr 2013 Author URL DOI

Trabectedin for the Treatment of AdvancedMetastatic Soft Tissue Sarcoma: A NICE Single Technology Appraisal.

Rafia R, Simpson E, Stevenson M, Papaioannou D

Pharmacoeconomics 09 Apr 2013 Author URL DOI